Design, synthesis and biological evaluation of quinazolin-4(3H)-one Schiff base conjugates as potential antiamoebic agents
![Thumbnail](/dspace/bitstream/handle/2183/38891/Avecilla_Porto_Fernando_2018_Design_synthesis_and_biological_evaluation_of_quinazolin.pdf.jpg?sequence=5&isAllowed=y)
Ver/Abrir
Use este enlace para citar
http://hdl.handle.net/2183/38891
Excepto si se señala otra cosa, la licencia del ítem se describe como CC BY-NC-ND 4.0 Attribution-NonCommercial-NoDerivatives 4.0 International
Colecciones
Metadatos
Mostrar el registro completo del ítemTítulo
Design, synthesis and biological evaluation of quinazolin-4(3H)-one Schiff base conjugates as potential antiamoebic agentsFecha
2018Cita bibliográfica
Tariq, S., Avecilla, F., Sharma, G. P., Mondal, N., & Azam, A. (2018). Design, synthesis and biological evaluation of quinazolin-4(3H)-one Schiff base conjugates as potential antiamoebic agents. Journal of Saudi Chemical Society, 22(3), 306-315. https://doi.org/10.1016/J.JSCS.2016.05.006
Resumen
[Abstract] In an effort to develop novel antiamoebic scaffolds having better efficacy than the standard drug metronidazole (IC50 = 1.80 μM) used against Entamoeba histolytica, quinazolin-4(3H)-one Schiff base conjugates were synthesized and evaluated against HM1: IMSS strain of E. histolytica. Out of the thirteen compounds (S2-S14), six compounds (S2, S3, S4, S5, S6 and S11) were found to be better inhibitors than metronidazole and showed low cytotoxicity on HeLa cells, a cervical cancer cell line. The structure of intermediate compound S1 was confirmed by crystal structure studies.
Palabras clave
Amebiasis
MTT assay
Antiamoebic activity
1,2,4-Triazole
MTT assay
Antiamoebic activity
1,2,4-Triazole
Versión del editor
Derechos
CC BY-NC-ND 4.0 Attribution-NonCommercial-NoDerivatives 4.0 International